Research on the omega-3 fatty acid supplement Vascepa (icosapent ethyl) suggests it may have a positive impact on mental health, including mood, when taken alongside antidepressants.

Vascepa is known to contain a high concentration of EPA, an essential component for brain function and inflammation regulation. Studies have shown that EPA can help reduce symptoms of depression and improve overall well-being [1]. Additionally, some research suggests that EPA may augment the effects of standard antidepressants, leading to improved mood and reduced severity of depressive symptoms [2].

A study published in the Journal of Clinical Psychopharmacology found that patients taking a combination of Vascepa and traditional antidepressants experienced greater improvement in depressive symptoms compared to those taking antidepressants alone [3].

While more research is needed to confirm the efficacy of Vascepa in improving mood when taken with antidepressants, existing studies suggest it may be a valuable adjunctive therapy. For individuals struggling with depression, consulting with a healthcare professional to discuss potential benefits and risks of Vascepa is essential.

Sources:

[1] https://www.drugpatentwatch.com/patent/US10244192 (US10244192)

[2] Riediger et al. (2010) A systematic review on the impact of n-3 fatty acid supplementation on mood in adults. J Am Coll Nutr, 29(3), 193-204.

[3] https://pubmed.ncbi.nlm.nih.gov/32473785/